Oncolytics Biotech (ONCY) EBIT (2009 - 2025)
Oncolytics Biotech's (ONCY) quarterly EBIT came in at -$10.6 million in Q3 2025, down 52.71% year-on-year from -$22.5 million in Q3 2024, and down 121.27% on a QoQ basis from -$4.8 million in Q2 2025.
Oncolytics Biotech (ONCY) EBIT (2009 - 2025) Analysis & Trends
Oncolytics Biotech (ONCY) has 17 years of EBIT data on file, last reported at -$10.6 million in Q3 2025.
- On a quarterly basis, EBIT fell 52.71% year-over-year to -$10.6 million in Q3 2025; TTM through Sep 2025 was -$28.1 million, a 269.93% decrease from a year earlier, with the FY2025 full-year figure at -$28.7 million, down 12.42% from the prior year.
- EBIT for Q3 2025 stood at -$10.6 million, down from -$4.8 million in the prior quarter.
- Over the last five years, EBIT for ONCY reached as high as $7.4 million in Q3 2023 and fell as low as -$35.6 million in Q4 2021.
- Historically, EBIT has averaged -$6.2 million across 5 years, with a median of -$5.1 million in 2021.
- On a YoY basis, EBIT climbed as much as 333.77% in 2023 and fell as far as 241.73% in 2023.
- Year by year, EBIT stood at -$35.6 million in 2021, then advanced by 15.42% to -$30.1 million in 2022, then surged by 90.66% to -$2.8 million in 2023, then tumbled by 102.55% to -$5.7 million in 2024, then sank by 86.56% to -$10.6 million in 2025.
- Per Business Quant data, the three most recent EBIT figures were -$10.6 million in Q3 2025, -$4.8 million in Q2 2025, and -$5.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -10.62 Mn |
| Jun 30, 2025 | -4.80 Mn |
| Dec 31, 2024 | -5.69 Mn |
| Sep 30, 2024 | -6.96 Mn |
| Jun 30, 2024 | -5.20 Mn |
| Dec 31, 2023 | -2.81 Mn |
| Sep 30, 2023 | 7.38 Mn |
| Jun 30, 2023 | -5.56 Mn |
| Mar 31, 2023 | -4.83 Mn |
| Dec 31, 2022 | -30.08 Mn |
| Sep 30, 2022 | -3.16 Mn |
| Jun 30, 2022 | 3.92 Mn |
| Mar 31, 2022 | -5.37 Mn |
| Dec 31, 2021 | -35.57 Mn |
| Sep 30, 2021 | 3.82 Mn |
| Jun 30, 2021 | 5.95 Mn |
| Mar 31, 2021 | -5.11 Mn |
| Dec 31, 2020 | 27.37 Mn |
| Sep 30, 2020 | -5.10 Mn |
| Jun 30, 2020 | -5.02 Mn |